Apervita, Inc.

Apervita, Inc. specializes in delivering innovative technology solutions that enhance efficiency in healthcare and other sectors, providing tailored tools to meet the unique needs of its diverse clientele. Founded in 2011 in Chicago, US, Apervita, Inc. focused on developing technology solutions aimed at improving operations within the healthcare sector.

The company underwent a strategic transformation with its Value Optimization business being acquired by Clarify Health Solutions, Inc. in August 2021, which positioned it to enhance its delivery of clinical improvement solutions. The company completed its most recent funding round in October 2021, raising USD 22. 56 mn, led by investors such as Baird Capital Partners and Illinois Ventures.

To date, Apervita has engaged in a total of 8 funding deals. Apervita's core offerings include technology solutions that address critical challenges in sectors like healthcare, technology, and consumer goods. The company provides proprietary tools and platforms designed for both individual customers and businesses, enhancing operational efficiency and user experience. Over the years, Apervita has strategically released products that cater to the diverse needs of markets across North America, Europe, and select regions in Asia.

Apervita generates revenue through a combination of direct sales and subscription services, providing a steady income stream from its varied clientele. The company's business model facilitates B2B partnerships that allow businesses to integrate its products into their operations, enhancing their service offerings. Clients can engage in bulk purchasing or subscription plans, tailored to reflect the value of the proprietary technologies that improve productivity and reduce costs. Following the acquisition of its Value Optimization business in October 2021, Apervita has ceased operations.

The acquisition by Clarify Health Solutions, Inc. is expected to enhance their capacity to deliver innovative payment and clinical improvement solutions. As of now, there are no announced plans for future product launches or market expansions.